Arca
Skip to content
Tools
Tools

GRIN2A: Glutamate receptor ionotropic, NMDA 2A

Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+).

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on GRIN2A, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Dextromethorphan

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        DextromethorphanApprovedEli LillySmall moleculeAntagonistGlutamate [NMDA] receptor subunit epsilon 1 antagonist22

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).DextromethorphanPhase 1Not yet recruitingEli Lilly and CompanyOct 20, 2026
        A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult SubjectsDextromethorphanPhase 1RecruitingBasilea PharmaceuticaOct 19, 2026
        Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILDDextromethorphanPhase 4Not yet recruitingPost Graduate Institute of Medical Education and Research, ChandigarhOct 6, 2026
        Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)DextromethorphanPhase 3RecruitingAxsome Therapeutics, Inc.Aug 14, 2026
        A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy ParticipantsDextromethorphanPhase 1RecruitingEisai Inc.Aug 14, 2026
        An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative ColitisDextromethorphanPhase 1RecruitingHoffmann-La RocheJun 24, 2026
        Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive DisorderDextromethorphanPhase 1 / Phase 2RecruitingMclean HospitalMay 18, 2026
        Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)DextromethorphanPhase 2Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical UniversityMay 13, 2026

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        • Landau-Kleffner syndrome0.84
        • Self-limited epilepsy with centrotemporal spikes0.69
        • Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation0.67
        • Parkinson disease0.62
        • Alzheimer disease0.62
        • Seizure0.61
        • Nasal congestion0.60

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1972, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt Q12879, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.